InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Winton Matthew. Director active across 1 company, notably Inozyme Pharma, Inc.. Aggregated, 5 filings have been logged. History available since 28 March 2024. The latest transaction was disclosed on 1 July 2025 (U). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Winton Matthew is a declarant linked to Inozyme Pharma, Inc. (XNAS), where he is listed as COO. The record shows 4 filings in total, and across the 4 sampled filings the modal transaction nature is Attribution, with dates ranging from 2024-04-03 to 2025-06-27.